CN Patent

CN102227424A — 囊性纤维化跨膜传导调节因子的调节剂

Assigned to Vertex Pharmaceuticals Inc · Expires 2011-10-26 · 15y expired

What this patent protects

本发明涉及囊性纤维化跨膜传导调节因子(“CFTR”)的调节剂、其组合物及其方法。本发明还涉及使用CFTR的调节剂(I)或其药学上可接受的盐治疗疾病的方法其中，环A选自：

USPTO Abstract

本发明涉及囊性纤维化跨膜传导调节因子(“CFTR”)的调节剂、其组合物及其方法。本发明还涉及使用CFTR的调节剂(I)或其药学上可接受的盐治疗疾病的方法其中，环A选自：

Drugs covered by this patent

Patent Metadata

Patent number: CN102227424A
Jurisdiction: CN
Classification: —
Expires: 2011-10-26
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.